EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Sodium Acetate Liposomes for Hepatocytes and Kupffer Cells: An Oral Dual-Targeted Therapeutic Approach for Non-Alcoholic Fatty Liver Disease Alleviation

Yichao Hou, Xilong Gao, Jiahui Gong, Xinrui Dong, Yanling Hao, Zhengyuan Zhai iD, Hao Zhang iD, Ming Zhang iD, Rong Liu, Ran Wang, Liang Zhao iD

Nutrients · 2025

DOI: 10.3390/nu17050930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Yichao Hou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Functional Dairy, Department of Nutrition and Health, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Kupffer Cells, Hepatocytes, Sodium Acetate. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the 111 Project from the Education Ministry of China, the 2115 Talent Development Program of China Agricultural University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Sodium acetate (NaA) has demonstrated potential in improving non-alcoholic fatty liver disease (NAFLD) by targeting hepatocytes and Kupffer cells. However, its clinical application is hindered by low oral bioavailability and insufficient liver concentrations. Liposomes, with their capacity to encapsulate water-soluble drugs and be surface-modified, offer a promising solution for targeted oral drug delivery.

Methods

We designed NaA-loaded liposomes modified with sodium cholate (SC) and mannose (MAN) (NaA@SC/MAN-LPs) to target hepatocytes and Kupffer cells.

Results

The NaA@SC/MAN-LPs had a mean diameter of approximately 100 nm with a positive surface charge. Compared to free NaA, NaA@SC/MAN-LPs significantly extended the serum half-life from 2.85 h to 15.58 h, substantially improving in vivo bioavailability. In vivo distribution studies revealed that NaA@SC/MAN-LPs extended the acetate peak time in the liver from 15 min to 60 min and increased hepatic acetate accumulation to 3.75 times that of free NaA. In in vitro cell experiments, NaA@SC/MAN-LPs significantly reduced the lipid droplet, triglycerides (TG), and total cholesterol (TC) in a fatty acid-induced hepatocyte steatosis model and suppressed proinflammation in a lipopolysaccharide (LPS)-activated Kupffer cell inflammation model. Free NaA effectively improved hepatic lipid deposition in NAFLD mice. Furthermore, NaA@SC/MAN-LPs decreased hepatic TG, TC, and the relative area of lipid droplets by 30.44%, 15.26%, and 55.83%, compared to free NaA. Furthermore, the liposomes reduced macrophage infiltration and pro-inflammatory response.

Conclusions

The NaA@SC/MAN-LPs demonstrated effective dual targeting effects on hepatocytes and Kupffer cells, significantly improving the pathogenesis of NAFLD, compared to free NaA. This study provides a new strategy for developing effective and safe oral drugs for NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseKupffer CellsHepatocytesSodium AcetateDrug Delivery SystemsAnimalsLiposomesMiceMaleAdministration, OralBiological AvailabilityMice, Inbred C57BLLiverHumansDisease Models, AnimalMannose

Stichwörter der Autor:innen

Kupffer cellhepatocyteliposomesnon-alcoholic fatty liver diseasesodium acetate

Substanzen

LiposomesSodium AcetateMannose

Autor:innen und Institutionen

  • Key Laboratory of Functional Dairy, Department of Nutrition and Health, China Agricultural University, Beijing 100193, China.
  • College of Food Science and Nutritional Engineering, China Agricultural University, Beijing 100083, China.
  • School of Food and Health, Beijing Technology and Business University, Beijing 100048, China.
  • Research Center for Probiotics, China Agricultural University, Beijing 101299, China.

ORCID-Profile: Zhengyuan Zhai, Hao Zhang, Ming Zhang, Liang Zhao

Förderung

  • the National Key Research and Development Program of China
  • the 111 Project from the Education Ministry of China
  • the 2115 Talent Development Program of China Agricultural University
  • National Key Research and Development Program of China
  • 111 Project from the Education Ministry of China
  • 2115 Talent Development Program of China Agricultural University

Zitieren

APA

Hou, Y., Gao, X., Gong, J., Dong, X., Hao, Y., Zhai, Z., Zhang, H., Zhang, M., Liu, R., Wang, R., & Zhao, L. (2025). Targeted Sodium Acetate Liposomes for Hepatocytes and Kupffer Cells: An Oral Dual-Targeted Therapeutic Approach for Non-Alcoholic Fatty Liver Disease Alleviation. Nutrients. https://doi.org/10.3390/nu17050930

Vancouver

Hou Y, Gao X, Gong J, Dong X, Hao Y, Zhai Z, et al. Targeted Sodium Acetate Liposomes for Hepatocytes and Kupffer Cells: An Oral Dual-Targeted Therapeutic Approach for Non-Alcoholic Fatty Liver Disease Alleviation. Nutrients. 2025. doi:10.3390/nu17050930

BibTeX
@article{Hou2025,
  author = {Hou, Yichao and Gao, Xilong and Gong, Jiahui and Dong, Xinrui and Hao, Yanling and Zhai, Zhengyuan and Zhang, Hao and Zhang, Ming and Liu, Rong and Wang, Ran and Zhao, Liang},
  title = {Targeted Sodium Acetate Liposomes for Hepatocytes and Kupffer Cells: An Oral Dual-Targeted Therapeutic Approach for Non-Alcoholic Fatty Liver Disease Alleviation},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17050930}
}
Kostenlos starten →